Yi-Wen Wu

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC

Ritu Ojha, Han-Li Huang, Wei‐Chun HuangFu et al. · European Journal of Medicinal Chemistry · 2018 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression

Samir Mehndiratta, Mei-Hsiang Lin, Yi-Wen Wu et al. · European Journal of Medicinal Chemistry · 2019 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity

Hsueh‐Yun Lee, Jiann-Fong Lee, Sunil Kumar et al. · European Journal of Medicinal Chemistry · 2016 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia

Liang‐Chieh Chen, Han-Li Huang, Wei‐Chun HuangFu et al. · Journal of Natural Products · 2020 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

4-Indolyl- N -hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo

Samir Mehndiratta, Ruei-Shian Wang, Han-Li Huang et al. · European Journal of Medicinal Chemistry · 2017 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7